![]() |
市場調查報告書
商品編碼
1625224
到 2030 年氧氣療法設備市場預測:按產品類型、便攜性、應用、最終用戶和地區分類的全球分析Oxygen Therapy Equipment Market Forecasts to 2030 - Global Analysis By Product Type (Oxygen Source Equipment and Oxygen Delivery Devices), Portability (Portable Devices and Stationary Devices), Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球氧氣療法設備市場規模為 48 億美元,預計預測期內複合年成長率為 9.5%,到 2030 年將達到 82 億美元。
氧氣療法設備由設計用於為患有慢性阻塞性肺病、氣喘和低氧血症等呼吸系統疾病的患者提供補充氧氣的設備組成。主要部件包括氧氣濃縮機、氣瓶、氧氣鼻管、面罩和可攜式氧氣系統,專為家庭、醫院和門診使用而量身定做。這些設備可確保最佳的氧氣輸送,以提高呼吸效率、增加氧氣飽和度並支援危急的醫療狀況。
據 CDC 稱,美國約有 1,600 萬成年人患有慢性阻塞性肺病(COPD)。
慢性呼吸道疾病增加
慢性阻塞性肺病、氣喘和肺纖維化等慢性呼吸系統疾病的盛行率不斷上升,是氧氣療法設備市場的主要促進因素。空氣污染、吸菸和老化等因素會導致這些症狀,許多患者需要長期氧氣療法。隨著人們對氧氣療法的好處及其在改善生活品質方面的作用的認知的提高,這種需求進一步放大。隨著這些呼吸系統疾病在全球範圍內持續增加,氧氣療法設備市場預計將大幅擴大。
設備高成本
先進氧氣療法設備的高成本是市場成長的主要限制。這些費用可能令人望而卻步,特別是對於許多低收入地區且沒有全面保險的患者而言。財務負擔也會影響醫療保健提供者投資尖端技術的能力,並限制獲得有效的呼吸照護解決方案。這些成本障礙導致護理品質的差異並阻礙市場發展,特別是在負擔能力成為關鍵問題的新興國家。
擴大家庭醫療保健服務
家庭醫療保健服務的擴張對於氧氣療法設備市場來說是一個巨大的機會。人們越來越偏好居家醫療,尤其是老年人和慢性病患者,這增加了對攜帶式且易於使用的氧氣設備的需求。這一趨勢得到了技術進步的支持,這些技術進步使設備更加便攜、更易於使用。隨著越來越多的患者選擇家庭治療以保持獨立性和舒適度,家庭氧氣療法設備市場有望顯著成長。
複雜的監管要求
複雜的監管要求對氧氣療法設備市場構成威脅。遵守美國FDA 和歐洲 CE 標誌等機構制定的嚴格標準對於進入市場至關重要,但對於製造商來說既困難又昂貴。儘管這些法規確保了安全性和有效性,但它們可能會延遲產品發布並增加開發成本。
由於患者呼吸系統併發症增加,COVID-19 大流行顯著增加了對氧氣療法設備的需求。這場危機凸顯了氧氣供應的重要性,並加速了其在醫院和家庭護理環境中的採用。需求的激增帶動了市場的快速創新和擴張,為疫情後的持續成長奠定了基礎。
氧源設備產業預計在預測期內規模最大
氧源設備領域預計將在預測期內佔據最大的市場佔有率,因為它在各種環境中提供氧氣療法發揮著至關重要的作用。該區域包括濃縮器、鋼瓶和流體系統,這些對於醫院的急診和家庭的長期護理至關重要。該領域的優勢在於需要穩定氧氣供應的呼吸系統疾病的盛行率不斷上升。
在預測期內,可攜式設備產業預計複合年成長率最高
預計可攜式設備領域在預測期內將呈現最高的複合年成長率。患者行動需求的增加和攜帶式技術的進步正在推動這一成長。可攜式設備提供便利性和靈活性,因此患者可以在接受所需治療的同時保持自己的生活方式。隨著技術創新不斷提高便攜性和效率,預計該領域將快速擴張。
由於北美地區發達的醫療基礎設施以及慢性阻塞性肺病和氣喘等呼吸道疾病的高盛行率,預計在預測期內將佔據最大的市場佔有率。有利的報銷政策和高醫療保健支出進一步支持了這一優勢。此外,主要製造商的進駐也顯著提升了北美市場佔有率。
由於人們對呼吸照護的認知不斷提高以及政府的支持措施,預計亞太地區將在預測期內實現最高的成長率。在中國和印度等國家,老年人口的成長和醫療基礎設施的改善推動了這一成長。隨著對先進醫療設備的需求增加,亞太地區正在成為全球市場的關鍵成長地區。
According to Stratistics MRC, the Global Oxygen Therapy Equipment Market is accounted for $4.8 billion in 2024 and is expected to reach $8.2 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Oxygen therapy equipment comprises devices designed to deliver supplemental oxygen to individuals with respiratory conditions such as COPD, asthma, or hypoxemia. Key components include oxygen concentrators, cylinders, nasal cannulas, masks, and portable oxygen systems, tailored for home, hospital, or ambulatory use. These devices ensure optimal oxygen delivery to improve breathing efficiency, enhance oxygen saturation levels, and support critical medical conditions.
According to the CDC, nearly 16 million adults in the United States have chronic obstructive pulmonary disease (COPD).
Rise in chronic respiratory conditions
The increasing prevalence of chronic respiratory conditions such as COPD, asthma, and pulmonary fibrosis is a major driver for the oxygen therapy equipment market. Factors like air pollution, smoking, and an aging population contribute to these conditions, necessitating long-term oxygen therapy for many patients. This demand is further amplified by the growing awareness of oxygen therapy's benefits and its role in improving quality of life. As these respiratory issues continue to rise globally, the market for oxygen therapy equipment is expected to expand significantly.
High costs of equipment
High costs associated with advanced oxygen therapy equipment are a significant restraint on market growth. These costs can be prohibitive for many patients, especially in low-income regions or for those without comprehensive insurance coverage. The financial burden also affects healthcare providers' ability to invest in the latest technologies, potentially limiting access to effective respiratory care solutions. This cost barrier can lead to disparities in treatment quality and hinder market expansion, particularly in developing countries where affordability is a critical concern.
Expansion of home healthcare services
The expansion of home healthcare services presents a significant opportunity for the oxygen therapy equipment market. With a growing preference for home-based care, particularly among the elderly and those with chronic conditions, demand for portable and user-friendly oxygen devices is increasing. This trend is supported by technological advancements that enhance device portability and ease of use. As more patients opt for home-based treatments to maintain independence and comfort, the market for home-use oxygen therapy equipment is poised for substantial growth.
Complex regulatory requirements
Complex regulatory requirements pose a threat to the oxygen therapy equipment market. Compliance with stringent standards set by bodies such as the FDA in the U.S. or CE marking in Europe is essential for market entry but can be challenging and costly for manufacturers. These regulations ensure safety and efficacy but can delay product launches and increase development costs.
The COVID-19 pandemic significantly boosted the demand for oxygen therapy equipment due to increased respiratory complications among patients. The crisis highlighted the importance of accessible oxygen supplies, accelerating adoption in both hospital and homecare settings. This surge in demand led to rapid innovations and expansions within the market, setting a foundation for sustained growth even post-pandemic.
The oxygen source equipment segment is expected to be the largest during the forecast period
The oxygen source equipment segment is expected to account for the largest market share during the forecast period due to its essential role in delivering oxygen therapy across various settings. This segment includes concentrators, cylinders, and liquid systems that are vital for both acute care in hospitals and long-term management at home. Its dominance is driven by the rising incidence of respiratory diseases requiring consistent oxygen supply.
The portable devices segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the portable devices segment is expected to witness the highest CAGR. The increasing need for mobility among patients and advancements in portable technology drive this growth. Portable devices offer convenience and flexibility, enabling patients to maintain their lifestyle while receiving necessary therapy. As innovations continue to enhance portability and efficiency, this segment's rapid expansion is anticipated.
The North America region is anticipated to account for the largest market share during the forecast period due to its advanced healthcare infrastructure and high prevalence of respiratory diseases like COPD and asthma. Favorable reimbursement policies and significant healthcare expenditure further support this dominance. The presence of leading manufacturers also contributes to North America's substantial market share.
The Asia Pacific region is anticipated to register the highest growth rate over the forecast period due to increasing awareness about respiratory care and supportive government initiatives. The rising geriatric population and improving healthcare infrastructure in countries like China and India bolster this growth. As demand for advanced medical devices increases, Asia Pacific emerges as a key growth region in the global market landscape.
Key players in the market
Some of the key players in Oxygen Therapy Equipment Market include Koninklijke Philips N.V., ResMed Inc., Invacare Corporation, Fisher & Paykel Healthcare Corporation Limited, AirSep Corporation, Dragerwerk AG & Co. KGaA, GE Healthcare, Medtronic PLC, Smiths Medical, Teleflex Incorporated, Drive DeVilbiss Healthcare, Nidek Medical Products Inc., O2 Concepts LLC, Inogen Inc., Chart Industries, Taiyo Nippon Sanso Corporation, Vyaire Medical Inc. and Precision Medical Inc.
In November 2023, Fisher & Paykel Healthcare Corporation Limited announced today it has released the Airvo 3 high flow system, which builds upon the market-leading Airvo 2, offering more advanced technology and a broader range of features for oxygen therapy delivery.
In June 2023, Philips has announced that the SimplyGo Mini portable oxygen concentrator conforms to FAA standards, making it available for on-board aircraft use, providing a new option for chronic respiratory patients who are on-the-go.
In February 2023, React Health subsidiary Ventec Systems has acquired Invacare's respiratory assets, including various oxygen therapy products. "With this acquisition, React Health is well positioned to continue to support the end-to-end care of patients with cardiology, sleep and respiratory illnesses, in partnership with physicians and providers of diagnostic and needed therapies," said Tom Pontzius, president of operations for React Health.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.